Lannett Inc (LCINQ) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Lannett Company Inc  (NONE: LCINQ)
 

Lannett Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lannett Inc's inventory turnover ratio, the ratio that measures Lannett Inc's ability to manage its supply chain, sequentially decreased to 2.73 in the third quarter 2023, but it does not raise any concerns as Lannett Inc continue to execute well, and the inventory turnover ratio remains above the average. Lannett Inc's average inventory processing period in the Mar 31 2023 quarter, has increased to 134 days, from 129 days, in the Dec 31 2022 quarter.

Within Healthcare sector 169 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 1038, from total ranking in the second quarter 2023 at 1136.

LCINQ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lannett Company Inc Market Share?

What is Inventory Turnover Ratio?




LCINQ Inventory Turnover Ratio (Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
(Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
Y / Y Inventory Growth -4.85 % -10.4 % -16.44 % -13.13 % -15.6 %
Y / Y Cost of Sales Growth -14.6 % -19.23 % -30.23 % -21.51 % -12.38 %
Inventory Turnover Ratio (TTM) 2.73 2.82 2.9 3.03 3.09
LCINQ's Total Ranking # 1038 # 1136 # 1213 # 1213 # 1213
Average inventory processing period 133 130 126 121 118
Seq. Inventory Growth -4.19 % 0.7 % -1.09 % -0.29 % -9.78 %
Seq. Cost of Sales Growth -1.48 % 6.48 % -6.32 % -13.09 % -6.83 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 55
Healthcare Sector # 170
Overall Market # 1038

Inventory Turnover Ratio Statistics
High Average Low
3.41 1.64 0.19
(Sep 30 2021)   (Jun 30 2016)




Financial Statements
Lannett Inc's Inventories $ 91 Millions Visit LCINQ's Balance sheet
Lannett Inc's Cost of Revenues TTM $ 256 Millions Visit LCINQ's Income Statement
What are LCINQ's Sales? Visit LCINQ's Sales by Segment

Other Inventory Turnover Ratios
Lannett Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LCINQ's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LCINQ's Competitors
Inventory Turnover Ratio for LCINQ's Suppliers
Inventory Turnover Ratio for LCINQ's Customers

You may also want to know
LCINQ's Sales Growth Rates LCINQ's Pe Price to earnings ratio LCINQ's Receivables Turnover Ratio LCINQ's Stock Quote
LCINQ's Net Income Growth Rates LCINQ's Ps Price to Sales ratio LCINQ's Sales per Employee LCINQ's Asset Turnover Ratio
LCINQ's Net Margin LCINQ's Pb Price to Book ratio LCINQ's Financial Strength Ratios LCINQ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Dmk Pharmaceuticals Corporation  7.58 $ 6.512  Millions$ 1  Millions
National Vision Holdings Inc   7.58 $ 943.602  Millions$ 125  Millions
Star Equity Holdings Inc   7.47 $ 83.998  Millions$ 11  Millions
Societal Cdmo Inc   7.09 $ 70.241  Millions$ 10  Millions
Nutriband Inc   6.90 $ 1.306  Millions$ 0  Millions
Opko Health Inc   6.84 $ 520.405  Millions$ 76  Millions
Novan Inc   6.70 $ 8.458  Millions$ 1  Millions
Collegium Pharmaceutical Inc   6.45 $ 357.740  Millions$ 55  Millions
Inogen Inc   6.18 $ 219.758  Millions$ 36  Millions
Hims and Hers Health Inc   6.12 $ 128.981  Millions$ 21  Millions
Fonar Corporation  6.09 $ 15.402  Millions$ 3  Millions
Patterson Companies Inc   5.85 $ 5,098.526  Millions$ 872  Millions
Nabriva Therapeutics Plc  5.73 $ 29.658  Millions$ 5  Millions
Veracyte Inc   5.53 $ 77.442  Millions$ 14  Millions
Carlisle Companies Incorporated  5.47 $ 4,261.200  Millions$ 779  Millions
Cryoport inc   5.47 $ 139.188  Millions$ 25  Millions
Alimera Sciences Inc  5.32 $ 8.325  Millions$ 2  Millions
Cti Biopharma Corp   5.31 $ 4.460  Millions$ 1  Millions
Avantor Inc   5.27 $ 4,804.600  Millions$ 911  Millions
Adm Tronics Unlimited Inc   5.22 $ 2.019  Millions$ 0  Millions
Ufp Technologies Inc   5.19 $ 278.476  Millions$ 54  Millions
Integer Holdings Corporation  5.10 $ 1,069.765  Millions$ 210  Millions
Exact Sciences Corporation  5.05 $ 596.555  Millions$ 118  Millions
Neptune Wellness Solutions Inc   5.03 $ 45.695  Millions$ 9  Millions
Horizon Therapeutics Public Limited Company  5.02 $ 913.698  Millions$ 182  Millions
Abbvie Inc   4.96 $ 17,348.000  Millions$ 3,495  Millions
Sanuwave Health Inc   4.92 $ 5.256  Millions$ 1  Millions
Incyte Corporation  4.83 $ 221.205  Millions$ 46  Millions
Catalyst Pharmaceuticals Inc   4.79 $ 38.449  Millions$ 8  Millions
Inspire Medical Systems inc   4.71 $ 75.999  Millions$ 16  Millions

Date modified: 2026-08-29T17:13:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.